A first-in-human, double-blind, randomised, placebo-controlled, dose ascending study of intra-articular rhFGF18 (sprifermin) in patients with advanced knee osteoarthritis

Category Primary study
JournalCLINICAL AND EXPERIMENTAL RHEUMATOLOGY
Year 2016
This article has no abstract
Epistemonikos ID: 7165f301da3a48a25450d1277910b436c5fee6e6
First added on: Nov 20, 2025